Seromadesis following total hip resurfacing by aspiration and injection of doxycycline

Loading

  1. http://orcid.org/0000-0003-1964-9822Adam James Farrier and
  2. Jim Holland
  1. Trauma and Orthopaedics, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, Tyne and Wear, UK
  1. Correspondence to Mr Adam James Farrier; c0062352{at}newcastle.ac.uk

Abstract

Here, we present an interesting case of seroma following hip resurfacing arthroplasty in a 69-year-old man. During the postoperative recovery, the patient made rapid progress and returned to intense activity within the 6-week period. He subsequently developed further right hip pain and swelling. On further examination and on ultrasound scan, a lateral thigh collection was noted. All inflammatory markers were within normal parameters; clinically, there was no evidence of active infection. On initial aspiration and washout, there was a large sterile haemoserous collection. The patient subsequently underwent further aspiration due to persistent collection. After this a revision procedure was performed in two stages with excision of the seroma cavity superficial to fascia lata. Methicillin-sensitive Staphylococcus aureus was grown on extended cultures which was treated successfully with antibiotics. After the second stage revision to total hip replacement, this cavity then recollected. A further trial of aspiration with injection of 200 mg doxycycline, a known sclerosing agent, was performed. The seroma resolved.

  • hip implants
  • prosthesis failure
  • hip prosthesis implantation
  • orthopaedic and trauma surgery

Statistics from Altmetric.com

  • hip implants
  • prosthesis failure
  • hip prosthesis implantation
  • orthopaedic and trauma surgery

Background

A seroma is a pocket of clear serous fluid that forms within the body after surgery. The fluid is composed of blood plasma and may form following disruption of lymphatic channels and the exudative inflammatory fluid produced from damage to bodily tissue during surgery.1 A surgically or traumatically created dead space leads to the accumulation of lymphatic, inflammatory and exudative fluids that prevent tissue adhesion.2 Seromas remain a trepid and difficult surgical complication. Different treatment options including external compression, percutaneous aspiration and additional surgical intervention which have all been used with variable success. Accessing the sterile fluid within the cavity percutaneously increases the risk for seeding bacteria into the seroma leading to an infected collection. The use of sclerotherapy in the management of seromas has been reported in small-scale studies and case reports, and has shown strong success with minimal complications.3 Any improvement in our ability to treat this challenging complication is of great importance.

Case presentation

Here, we present an interesting case of seroma following hip resurfacing arthroplasty. A 69-year-old motivated and physically active family lawyer presented with osteoarthritis of the right hip. He previously had a successful hip resurfacing as treatment for left hip osteoarthritis without complication. His index right hip resurfacing with an Adept Hip Resurfacing implant (MatOrtho, Leatherhead, UK) was performed in November 2015 by JH, the lead author who has extensive experience in hip resurfacing. This procedure was performed without immediate complication. The immediate postoperative course was uneventful with Tinzaparin prescribed for venous thromboembolism prophylaxis. Advice was given to avoid excessive activity during the postoperative recovery; however, the patient made rapid progress and returned to intense activity within the 6-week period. His increased activity included a return to full-time work and driving after 3 weeks, spinning classes; 30 min to an hour daily after 5 weeks and a long trip to a wedding by train at around 6 weeks. He felt very confident given his expedient recovery and the successful outcome of the same surgery on the contralateral hip. He subsequently developed further right hip pain and thigh swelling. On further assessment at 7 weeks, a lateral thigh collection was noted.

Investigations

Radiographs and blood tests were sent. The postoperative anteroposterior (AP) pelvis radiographs was as shown in figure 1, which was deemed satisfactory. All inflammatory markers including full blood count, erythrocyte sedementation rate (ESR) and C reactive protein were within normal parameters and clinically, there was no evidence of active infection. In December 2015, an ultrasound was performed identifying a loculated fluid collection measuring 86×60×22 mm as shown in figure 2. An aspiration was performed with 800 mL haemoserous fluid removed followed by an open washout with multiple (seven) samples sent intraoperatively. Prophylactic antibiotics moxifloxacin 400 mg one time a day was commenced pending extended culture results (7 days extended anaerobic, mycobacterium and fungi for 21 days). The collection proved to be sterile on extended culture and antibiotics were stopped. Further review in April 2016 showed a persistent collection on examination. Bloods were repeated and the inflammatory markers remained within normal parameters (C-Reactive Protein (CPR)<5, Erythrocyte Sedimentation Rate (ESR) 5, White Cell Count (WCC) 7.07). Further, ultrasound scan (USS) showed a persistent collection measuring 76×40×30 mm as shown in figure 3. Repeat aspiration was also sterile on extended culture with a negative alpha-defensin. Following the second aspiration the distal end of the surgical scar began to leak serous fluid and a sinus developed. In May 2016, after multidisciplinary team discussion despite negative cultures, a two-stage revision surgery was opted for after counselling the patient. During the first stage procedure, a full debridement of the seroma cavity, superficial to fascia lata, was performed and extensive tracking of the seroma down the lateral thigh was observed with multiple samples of fluid and tissue sent for culture and sensitivities. The hip resurfacing was excised and an antibiotic loaded cement spacer (COPAL, Heraeus, Germany) was placed. Intravenous teicoplanin 400 mg twice daily (BD) was commenced as advised by our hospital microbiologists pending extended culture results. The postoperative AP pelvis is shown in figure 4. After extended culture from samples sent at the time of surgery, a low-grade infection with methicillin-sensitive Staphylococcus aureus was identified on three of the seven samples taken intraoperatively. Antibiotics were stepped down to oral trimethoprim 200 mg two times a day and moxifloxacin 400 mg one time a day for 6 weeks as advised. In August 2016, the inflammatory markers were within normal limits and the soft tissues were quiescent. A second stage revision was performed using a hybrid total hip replacement system; Exeter stem, copal cement and uncemented trident acetabular component with three screws placed into the ileum. Multiple samples of fluid and tissue were taken as per local protocol at the time of second stage surgery which did not grow any organism on extended culture. The postoperative radiograph is shown in figure 5. Frustratingly at the 6 weeks follow-up in September 2016, the seroma had returned clinically however all inflammatory blood markers remained within normal limits. A close surveillance strategy was opted for after discussion with the patient. In January 2017, the seroma persisted, measuring 41×6×11 cm on USS (figure 6). In June 2017, a further aspiration was attempted at the patients request with over 1 L of fluid aspirated which proved to be sterile on culture (figure 7). The seroma then recollected (figure 8).

Treatment

After further discussion with our plastic surgical colleague, a further aspiration was performed in theatre with the instillation of 200 mg doxycycline. This was discussed with the hospital formulary committee who, based on literature evidence for its use, approved this non-formulary use for this case. A single dose of doxycycline was used and no further treatment was required. Finally, with great relief, as of May 2018 the seroma had fully resolved with no palpable seroma identified clinically.

Outcome and follow-up

The patient underwent complex reconstructive surgery due to difficulty managing the seroma around the hip. At the time of writing, he remains independently mobile, is still working full time and he continues with his spinning classes with a satisfactory outcome from a complex complication. The seroma remains fully resolved.

Discussion

A seroma is a pocket of clear serous fluid that forms within the body after surgery. A surgically or traumatically created dead space leads to the accumulation of lymph, inflammatory and exudative fluid which prevents tissue adhesion.1 The fluid is composed of blood plasma from leaky vessels, disrupted lymphatic channels and the exudative inflammatory fluid produced from damaged cells.2 Seromas remain a trepid and difficult surgical complication. Different treatment options include external compression, percutaneous aspiration and additional surgical interventions with varied success. In this case, there may have been an additional inflammatory exudate due to fine element wear debris produced from the metal-on-metal hip resurfacing implant. This may have been exacerbated by an early, rapid progression to intense physical activity during the postoperative period. Seromas remain a trepid and difficult surgical complication. Current treatment options include compression, percutaneous aspiration and possible additional surgical interventions. Accessing the sterile fluid within the cavity poses a risk for contaminating the seroma with commensal organisms resulting in infection. The use of sclerotherapy in the management of seromas has been reported in small scale studies and case reports, and has shown strong success with minimal complications.3 In this case, the initial aspiration and washout of the early postoperative haematoma collection did not succeed in preventing the seroma formation. Furthermore, the open washout and repeat aspiration, though negative for organisms on tissue culture, led to the formation of a small sinus and an infected seroma. This ultimately required two-stage revision surgery given the likely communication with the hip resurfacing implant. Despite excision of the pseudo-capsule that had formed during the second stage revision total hip replacement, the seroma recollected.

Tetracyclines in solution form are used topically for chemical pleurodesis in chest surgery.4 Doxycycline is a tetracycline antibiotic. Some studies have reported successful topical use of tetracyclines in solution as a treatment in seroma, taking advantage of their sclerosing effect in cases of reconstruction following breast surgery, abdominal and hernia surgery.5 6 Prophylactic use of doxycycline has been attempted as prophylaxis in groin hernia repair although this is of no proven benefit.7 The common adverse effects of chemical pleurodesis are pain, fever, and gastrointestinal symptoms.8 No such adverse effects were observed in this case. Tetracycline has been demonstrated to increase growth factor—like activity in mesothelial cells exposed to tetracycline. This leads to fibroblast proliferation and consequently fibrin formation that closes the dead space present in a seroma.9 In addition, the use of doxycycline in seroma provides local delivery of an antibiotic commonly used for skin and soft tissue infections; due to its efficacy against Staphylococcus aureus including methicillin-resistant Staphylococcus aureus. There has also previously been a reported case of successful seromadesis in breast surgery using doxycycline while erythromycin has been used in seromadesis following hip replacement suggesting that treatment is not limited to doxycycline.10 11

Learning points

  • It is crucial to exclude infection in arthroplasty-associated seroma treatment.

  • Multidisciplinary team involvement is fundamental.

  • Doxycycline is a safe and potentially curative treatment for seroma around the hip.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center's RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information:

© BMJ Publishing Group Limited 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Read the full text or download the PDF:

Log in using your username and password